Association between RCASI expression and clinical outcome in uterine endometrial cancer

British Journal of Cancer

Volumn 89, Issue 3, 2003, Pages 546-551

  Sonoda, K ^a   Miyamoto, S ^a   Hirakawa, T ^a   Kaku, T ^b   Nakashima, M ^b   Watanabe, T ^b   Akazawa, K ^c   Fujita, T ^a   Nakano, H ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Prognostic factors; RCASI; Uterine endometrial cancer

Indexed keywords

ANTINEOPLASTIC AGENT; MEMBRANE PROTEIN; PLATINUM; PROTEIN RCAS1; UNCLASSIFIED DRUG; EBAG9 PROTEIN, HUMAN; TUMOR ANTIGEN;

ADULT; AGE; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; ENDOMETRIUM CANCER; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; MYOMETRIUM; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT OUTCOME; BIOSYNTHESIS; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0041475723     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601126     Document Type: Article

References (48)

1. American Cancer Society (2002) Cancer Facts and Figures 2001. Atlanta: American Cancer Society
2. Bancher-Todesca D, Gitsch G, Williams KE, Kohlberger P, Neunteufel W, Obermair A, Heinze G, Breiteuecker G, Hacker NF (1998) p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma. Gynecol Oncol 71: 59-63
3. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11: 372-377
4. Chambers JT, MacLusky N, Eisenfield A, Kohorn EI, Lawrence R, Schwartz PE (1988) Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer. Gynecol Oncol 31: 65-81
5. DiSaia PJ, Creasman WT (1997) Adenocarcinoma of the uterus. In Clinical Gynecologic Oncology, 5th edn., DiSaia PJ, Creasmann WT (eds) pp 134-168. St Louis, MO: Mosby-Year Book
6. Ebert AD, Wechselberger C, Martinez-Lacaci I, Bianco C, Weizel HK, Salomon DS (2000) Expression and function of EGF-related peptides and their receptors in gynecological cancer - from basic science to therapy? J Recept Signal Transduct Res 20: 1-46
7. Enomoto T, Inoue M, Perantoni AO, Perantoui AO, Terakawa N, Tanizawa O, Rice JM (1990) K-ras activation in neoplasmas of the human female reproductive tract. Cancer Res 50: 6139-6145
8. Esteller M, Xercarvins J, Reventos J (1999) Advances in the molecular genetics of endometrial cancer. Oncol Rep 6: 1377-1382
9. Fan H, Derynck R (1999) Ectodomain shedding of TGF-alfa and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J 18: 6962-6972
10. Fujiwaki R, Hata K, Iida K, Maede Y, Watanabe Y, Koike M, Miyazaki K (1999) Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer. Acta Obstet Gynecol Scand 78: 728-734
11. Gastman BR, Atarashi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL (1999) Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res 59: 5356-5364
12. Hsu S, Raine L, Fanger H (1981) The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75: 816-821
13. Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S (2000) Promoter analysis and chromosomal mapping of human EBAG9 gene. Biochem Biophys Res Commun 273: 654-660
14. Ingram SS, Rosenman J, Heath R, Morgan TM, Moore D, Varia M (1989) The predictive value of progesterone receptor levels in endometrial cancer. Int J Radiat Oncol Biol Phys 17: 21-27
15. Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y, Yamanaka H, Matsumura A, Iuchi K, Mori T, Okada M (2000) Expression and prognostic significance in lung cancer of human tumour-associated antigen RCAS1. Int J Cancer 89: 488-493
16. Izumi M, Nakanishi Y, Yoshino I, Nakashima M, Watanabe T, Hara N (2001) Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell carcinoma. Cancer 92: 446-451
17. Japan Society of Obstetrics Gynecology (1998) Statement for the year 1987, inclusive, corpus. Acta Obstet Gynaec Jpn 50: 295-305
18. Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, Amada S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T, Nakano H (1999) The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 5: 1449-1453
19. Khalifa MA, Abdoh AA, Mannel RS, Haraway SD, Walker JL, Min KW (1994) Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma. Cancer 73: 370-376
20. Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Sopen JT, Clarke-Pearson DL, Bast Jr RC, Marks JR (1992) Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52: 1622-1627
21. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW (2000) Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol 13: 379-388
22. Kubokawa M, Nakashima M, Yao T, Ito KI, Harada N, Nawata H, Watanabe T (2001) Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 19: 695-700
23. Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M (2001) Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metabol 86: 1379-1386
24. Maxwell GL, Risinger JI, Grumbs C, Shaw H, Bentley RC, Barret JC, Barchuck A, Futreal PA (1998) Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 58: 2500-2503
25. Morgan KG, Wilkinson N, Buckley CH (1996) Angiogenesis in endometrial carcinoma. Int J Gynecol Cancer 6: 385-388
26. Miyamoto S, Maruyama A, Okugawa K, Akazawa K, Baba H, Maehara Y, Mekada E (2001) Loss of motility-related protein1 (MRP1/CD9) and integrin α3 expression in endometrial cancers. Cancer 92: 542-548
27. Nakashima M, Sonoda K, Watanabe T (1999) Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 5: 938-942
28. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
29. Nath D, Williamson NJ, Jarvis R, Murphy G (2001) Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase. J Cell Sci 114: 1213-1220
30. National Cancer Centre (2002) Cancer Statistics in Japan 2001. Tokyo: National Cancer Centre
31. Niikura H, Sasano H, Matsunaga G, Watanabe K, Ito K, Sato S, Yajima A (1995) Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma. Hum Pathol 26: 892-896
32. Niwa K, Murase T, Morishita S, Hashimoto M, Itoh N, Tamaya T (1999) p53 overexpression and mutation in endometrial carcinoma: inverted relation with estrogen and progesterone receptor status. Cancer Detect Prev 23: 147- 154
33. Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H, Choi I, Taguchi K, Kotoh K, Shimada K, Tsuneyoshi M, Nawata H, Watanabe T (2001) Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 168: 197-202
34. Nordstrom B, Strang P, Bergstrom R, Nilsson S, Tribukait B (1996) A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction. 78: 1942-1951
35. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184: 1075-1082
36. Ohno S, Tachibana M, Shibakita M, Dhar DK, Yoshimura H, Kinugasa S, Kubota H, Masunaga R, Nagasue N (2000) Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer. Ann Surg Oncol 7: 750-757
37. Ohshima K, Muta K, Nakashima M, Haraoka S, Tutiya T, Suzumiya J, Kawasaki C, Watanabe T, Kikuchi M (2001) Expression of tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion. Int J Cancer 93: 91-96
38. Razvi K, Sonoda K, Lee YS, Tham KF, Lim FK, Yong EL (1999) A preliminary study of the immunohistochemical detection of a novel tumour marker, 22-1-1 antigen, in gynaecological cancer specimens. Ann Acad Med Singapore 28: 392-394
39. Rolitsky CD, Theil KS, McGaughy VR, Copeland LJ, Niemann TH (1999) HER-2/neu amplification and overexpression in endometrial carcinoma. Int J Gynecol Pathol 18: 138-143
40. Sivridis E (2001) Angiogenesis and endometrial cancer. Anticancer Res 21: 4383-4388
41. Sivridis E, Giatromanolaki A, Koukourakis M, Anastasiadis P (2001) Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression. Virchows Arch 438: 470-477
42. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T (1996) A novel tumor-associated antigen expression in human uterine and ovarian carcinomas. Cancer 77: 1501-1509
43. Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H (1998) Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 4: 1517-1520
44. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H (2000) The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant endometrium. Gynecol Oncol 79: 424-429
45. Suzuki T, Inoue S, Kawabata W, Akahira J, Moriya T, Tsuchiya F, Ogawa S, Muramatsu M, Sasano H (2001) EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. Br J Cancer 85: 1731-1737
46. Takahashi H, Iizuka H, Nakashima M, Wada T, Asano K, Ishida-Yamamoto A, Watanabe T (2001) RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 26: 140-144
47. Umata T, Hirata M, Takahashi T, Ryu F, Shida S, Takahashi Y, Tsuneoka M, Miura Y, Masuda M, Horiguchi Y, Mekada E (2001) A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J Biol Chem 276: 30475-30482
48. Zietz C, Rumpler U, Sturzl M, Lohrs U (2001) Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma. Am J Pathol 159: 963-970